The IO:GULF Founding Team

---

Dr James Mitchell is a UK trained physician and pharma executive. He entered the industry as Lead Research Physician, and Clinical Manager for, London based contract research organisation, Richmond Pharmacology. He is experienced inmanagement and business development in the sector and the development and monitoring of  international clinical  trials and networks.

At Immunocore in Oxford, James was the Associate Director for Clinical Development. His primary focus was the next-generation PRAME program. Whilst there, he also led on AI trial strategy, US biomarker testing programs and global clinical trial network development across four continents.Our team of experts works tirelessly to discover new and innovative drugs that target a variety of diseases. We use state-of-the-art technology and cutting-edge research techniques to develop drugs that have the potential to change lives.

Dr Howard Goodall is a UK trained physician and pharma executive. As a principal investigator for clinical trials, Howard specialised in early phase oncology. He then moved onto industry roles. At Astellas, he was responsible for creating the UK Oncology function as well as the launch of the blockbuster drug, Xtandi. Howard then moved to Jazz Pharmaceuticals as Medical Director Europe/Rest of World.

At Immunocore, Howard was European and Global Head of Medical Affairs, leading development and commercialisation of tebentafusp. He then led the Global Clinical Programme Lead, spearheading global life cycle management strategy.Our biomedical engineers work on the design and development of medical devices and artificial organs. We use advanced materials and innovative techniques to create devices that improve the quality of life for patients.